デフォルト表紙
市場調査レポート
商品コード
1457967

補聴器の世界市場:市場規模・シェア分析 (製品別 (補聴装置、聴覚インプラント)・患者タイプ別 (成人、小児)・難聴別 (感音性、伝音性)・技術別 (従来型、デジタル))、産業需要の予測 (~2030年)

Hearing Aids Market Size and Share Report by Product (Hearing Aid Devices, Hearing Implants), Patient type (Adults, Pediatrics), Hearing Loss (Sensorineural, Conductive), Technology (Conventional, Digital) - Global Industry Growth Forecast to 2030

出版日: | 発行: Prescient & Strategic Intelligence | ページ情報: 英文 250 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
補聴器の世界市場:市場規模・シェア分析 (製品別 (補聴装置、聴覚インプラント)・患者タイプ別 (成人、小児)・難聴別 (感音性、伝音性)・技術別 (従来型、デジタル))、産業需要の予測 (~2030年)
出版日: 2024年02月01日
発行: Prescient & Strategic Intelligence
ページ情報: 英文 250 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の補聴器市場は、2023年に82億1,050万米ドルの規模に達し、2024年から2030年にかけて6.4%のCAGRで成長し、2030年には125億4,190万米ドルに達すると予測されています。

このような市場の成長は、難聴の発生が増加していること、聴覚障害にかかりやすい高齢者人口が増加していること、難聴や難聴の治療のための技術的に高度なツールに関する知識が高まっていること、両耳装用率が上昇していることなどが背景にあります。

市場をリードする成人カテゴリー

患者タイプ別では、近年では成人のカテゴリーが収益の70%を占めて業界をリードしており、予測期間中もこのカテゴリーは並外れた発展を見せると推定されています。

感音性難聴が市場で最大シェアを占める

難聴の種類別では、2023年に感音性難聴のカテゴリーが業界シェア75%で最大となり、予測期間中に大きな発展を見せると予測されます。

欧州が業界をリード

2023年には、欧州地域が約40%のシェアを占め、予測期間中もCAGRは堅調に推移すると予測されています。この背景には、難聴者の急増と、補聴器に役立つ政府の規則があります。さらに、医療機器へのアクセスを拡大するための効果的な政府の措置は、欧州地域における補聴器産業の売上高を押し上げると推定されます。

当レポートでは、世界の補聴器の市場について分析し、市場の基本構造・最新情勢や主な促進・抑制要因、世界全体および地域別・主要国の市場規模の動向見通し (数量・金額ベース、2017~2030年)、製品別・患者タイプ別・難聴の種類別・技術別の詳細動向、現在の市場競争の状況、主要企業のプロファイルなどを調査しております。

目次

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場指標

第5章 業界の展望

  • 市場力学
    • 動向
    • 促進要因
    • 抑制要因/課題
    • 促進要因/抑制要因の影響分析
  • 新型コロナウイルス感染症 (COVID-19) の影響
  • ポーターのファイブフォース分析

第6章 世界市場

  • 概要
  • 市場規模:製品別 (2017~2030年)
  • 市場収益:製品別 (2017~2030年)
  • 市場規模:患者タイプ別 (2017~2030年)
  • 市場収益:患者タイプ別 (2017~2030年)
  • 市場規模:難聴の種類別 (2017~2030年)
  • 市場収益:難聴の種類別 (2017~2030年)
  • 市場規模:技術別 (2017~2030年)
  • 市場収益:技術別 (2017~2030年)
  • 市場規模:地域別 (2017~2030年)
  • 市場収益:地域別 (2017~2030年)

第7章 北米市場

  • 概要
  • 市場規模:製品別 (2017~2030年)
  • 市場収益:製品別 (2017~2030年)
  • 市場規模:患者タイプ別 (2017~2030年)
  • 市場収益:患者タイプ別 (2017~2030年)
  • 市場規模:難聴の種類別 (2017~2030年)
  • 市場収益:難聴の種類別 (2017~2030年)
  • 市場規模:技術別 (2017~2030年)
  • 市場収益:技術別 (2017~2030年)
  • 市場規模:国別 (2017~2030年)
  • 市場収益:国別 (2017~2030年)

第8章 欧州市場

第9章 アジア太平洋市場

第10章 ラテンアメリカ市場

第11章 中東・アフリカ (MEA) 市場

第12章 米国市場

  • 概要
  • 市場規模:製品別 (2017~2030年)
  • 市場収益:製品別 (2017~2030年)
  • 市場規模:患者タイプ別 (2017~2030年)
  • 市場収益:患者タイプ別 (2017~2030年)
  • 市場規模:難聴の種類別 (2017~2030年)
  • 市場収益:難聴の種類別 (2017~2030年)
  • 市場規模:技術別 (2017~2030年)
  • 市場収益:技術別 (2017~2030年)

第13章 カナダ市場

第14章 ドイツ市場

第15章 フランス市場

第16章 英国市場

第17章 イタリア市場

第18章 スペイン市場

第19章 日本市場

第20章 中国市場

第21章 インド市場

第22章 オーストラリア市場

第23章 韓国市場

第24章 ブラジル市場

第25章 メキシコ市場

第26章 サウジアラビア市場

第27章 南アフリカ市場

第28章 アラブ首長国連邦 (UAE) 市場

第29章 競合情勢

  • 市場参入企業とその提供製品/サービスの一覧
  • 主要企業の競合ベンチマーク
  • 主要企業の製品ベンチマーク
  • 最近の戦略展開状況

第30章 企業プロファイル

  • Audina Hearing Instruments Inc.
  • Amplifon SpA
  • GN Group
  • Horentek Hearing Diagnostics
  • Cochlear Ltd.
  • Abbott Laboratories
  • Sonova Holding AG
  • Sivantos Group
  • EunSung
  • Arphi Electronics Private Limited

第31章 付録

目次
Product Code: 10540

The hearing aids market achieved a value of USD 8,210.5 million in 2023 and is projected to grow to USD 12,541.9 million by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4% between 2024 and 2030.

This growth of the market can be credited to the growing occurrence of hearing loss, the increasing elderly populace, which is vulnerable to hearing disorders; rising knowledge about technically advanced tools for the treatment of deafness and hearing loss, and also rising binaural fitting rate.

Market Drivers

Moreover, the arrival of enhanced technologies, like wirelessly linked devices with phones, is projected to impact the industry positively.

Also, the need for cochlear implants is progressively growing, particularly among kids.

As per the WHO's data, by 2050, around 2.5 billion individuals will have some kind of hearing loss, 2 in 20 individuals will have incapacitating hearing loss, and at least 800 million will need hearing therapy.

Additionally, because of risky listening habits, approximately 1 billion kids are in danger of evolving permanent, but avoidable hearing loss.

Improvements in Hearing Aid Technology

The integration of smart technologies and digital platforms with compact devices can help in improving the hearing experience for patients.

With Phonak's Paradise technology integrated into its Virto lineup of individual hearing aid devices in February 2022.

The private Virto P-Titanium bespoke titanium in-the-ear hearing aid completes this package.

The VitoP Black is a hybrid in-the-ear hearing aid that also resembles today's earbuds.

Growing Elderly Populace

The development in the worldwide elderly populace is also among the key reasons accountable for the growing occurrence of hearing issues. Apart from age, the rising contact with loud noises, hereditary susceptibility, and physiological aging of the ears might all pay to hear the loss in the aging populace.

To be more specific, based on WHO forecasts, around 14.9% of the global population will be aged 60+ by 2030.

Data from the UNFAO said that the number of the population aged 60 years and above would expand pretty fast. They were saying that the number in 2020 was around 1 billion and it will keep on growing to 1.4 billion.

Adults Category Is Leading the Market

In recent years, on the basis of patient type, the adult category led the industry, with 70% revenue, and the category is also estimated to show extraordinary development over the projection period.

Hearing aids are widely considered the main treatment option for hearing loss problems, leading to a surge in demand for these devices.

The increasing elderly population and rising awareness about the diverse range of hearing devices and implants in the market are key factors propelling market growth.

Technologically advanced devices are being embraced by elderly individuals due to their advantages and user-friendly features.

Sensorineural Hearing Loss Category Is Anticipated to Capture the Largest Share of The Market

In 2023, on the basis of type of hearing loss, the sensorineural hearing loss category had the largest industry share 75%, and it is estimated to showcase substantial development over the projection period.

Geriatrics are a substantial subsection of the total patient pool due to their high susceptibility to sensorineural hearing loss.

Elderly patients who have mild-to-moderate SNHS in both ears can benefit from hearing aids.

Europe Is Leading the Industry

In 2023, the European region held the largest share, of approximately 40%, and the region is also projected to advance at a robust CAGR over the projection period. This can be credited to the surge in the count of people with hearing loss and government rules that are helpful for assistive listening devices. Moreover, effective government steps to enlarge access to medicinal devices are estimated to boost the hearing aids industry sales revenue in the European region.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by product
    • 1.4.2. Market size breakdown, by patient type
    • 1.4.3. Market size breakdown, by type of hearing loss
    • 1.4.4. Market size breakdown, by technology
    • 1.4.5. Market size breakdown, by region
    • 1.4.6. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Volume
    • 1.5.2. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Volume, by Product (2017-2030)
  • 6.3. Market Revenue, by Product (2017-2030)
  • 6.4. Market Volume, by Patient Type (2017-2030)
  • 6.5. Market Revenue, by Patient Type (2017-2030)
  • 6.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 6.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 6.8. Market Volume, by Technology (2017-2030)
  • 6.9. Market Revenue, by Technology (2017-2030)
  • 6.10. Market Volume, by Region (2017-2030)
  • 6.11. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Volume, by Product (2017-2030)
  • 7.3. Market Revenue, by Product (2017-2030)
  • 7.4. Market Volume, by Patient Type (2017-2030)
  • 7.5. Market Revenue, by Patient Type (2017-2030)
  • 7.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 7.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 7.8. Market Volume, by Technology (2017-2030)
  • 7.9. Market Revenue, by Technology (2017-2030)
  • 7.10. Market Volume, by Country (2017-2030)
  • 7.11. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Volume, by Product (2017-2030)
  • 8.3. Market Revenue, by Product (2017-2030)
  • 8.4. Market Volume, by Patient Type (2017-2030)
  • 8.5. Market Revenue, by Patient Type (2017-2030)
  • 8.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 8.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 8.8. Market Volume, by Technology (2017-2030)
  • 8.9. Market Revenue, by Technology (2017-2030)
  • 8.10. Market Volume, by Country (2017-2030)
  • 8.11. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Volume, by Product (2017-2030)
  • 9.3. Market Revenue, by Product (2017-2030)
  • 9.4. Market Volume, by Patient Type (2017-2030)
  • 9.5. Market Revenue, by Patient Type (2017-2030)
  • 9.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 9.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 9.8. Market Volume, by Technology (2017-2030)
  • 9.9. Market Revenue, by Technology (2017-2030)
  • 9.10. Market Volume, by Country (2017-2030)
  • 9.11. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Volume, by Product (2017-2030)
  • 10.3. Market Revenue, by Product (2017-2030)
  • 10.4. Market Volume, by Patient Type (2017-2030)
  • 10.5. Market Revenue, by Patient Type (2017-2030)
  • 10.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 10.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 10.8. Market Volume, by Technology (2017-2030)
  • 10.9. Market Revenue, by Technology (2017-2030)
  • 10.10. Market Volume, by Country (2017-2030)
  • 10.11. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Volume, by Product (2017-2030)
  • 11.3. Market Revenue, by Product (2017-2030)
  • 11.4. Market Volume, by Patient Type (2017-2030)
  • 11.5. Market Revenue, by Patient Type (2017-2030)
  • 11.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 11.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 11.8. Market Volume, by Technology (2017-2030)
  • 11.9. Market Revenue, by Technology (2017-2030)
  • 11.10. Market Volume, by Country (2017-2030)
  • 11.11. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Volume, by Product (2017-2030)
  • 12.3. Market Revenue, by Product (2017-2030)
  • 12.4. Market Volume, by Patient Type (2017-2030)
  • 12.5. Market Revenue, by Patient Type (2017-2030)
  • 12.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 12.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 12.8. Market Volume, by Technology (2017-2030)
  • 12.9. Market Revenue, by Technology (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Volume, by Product (2017-2030)
  • 13.3. Market Revenue, by Product (2017-2030)
  • 13.4. Market Volume, by Patient Type (2017-2030)
  • 13.5. Market Revenue, by Patient Type (2017-2030)
  • 13.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 13.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 13.8. Market Volume, by Technology (2017-2030)
  • 13.9. Market Revenue, by Technology (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Volume, by Product (2017-2030)
  • 14.3. Market Revenue, by Product (2017-2030)
  • 14.4. Market Volume, by Patient Type (2017-2030)
  • 14.5. Market Revenue, by Patient Type (2017-2030)
  • 14.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 14.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 14.8. Market Volume, by Technology (2017-2030)
  • 14.9. Market Revenue, by Technology (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Volume, by Product (2017-2030)
  • 15.3. Market Revenue, by Product (2017-2030)
  • 15.4. Market Volume, by Patient Type (2017-2030)
  • 15.5. Market Revenue, by Patient Type (2017-2030)
  • 15.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 15.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 15.8. Market Volume, by Technology (2017-2030)
  • 15.9. Market Revenue, by Technology (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Volume, by Product (2017-2030)
  • 16.3. Market Revenue, by Product (2017-2030)
  • 16.4. Market Volume, by Patient Type (2017-2030)
  • 16.5. Market Revenue, by Patient Type (2017-2030)
  • 16.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 16.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 16.8. Market Volume, by Technology (2017-2030)
  • 16.9. Market Revenue, by Technology (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Volume, by Product (2017-2030)
  • 17.3. Market Revenue, by Product (2017-2030)
  • 17.4. Market Volume, by Patient Type (2017-2030)
  • 17.5. Market Revenue, by Patient Type (2017-2030)
  • 17.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 17.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 17.8. Market Volume, by Technology (2017-2030)
  • 17.9. Market Revenue, by Technology (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Volume, by Product (2017-2030)
  • 18.3. Market Revenue, by Product (2017-2030)
  • 18.4. Market Volume, by Patient Type (2017-2030)
  • 18.5. Market Revenue, by Patient Type (2017-2030)
  • 18.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 18.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 18.8. Market Volume, by Technology (2017-2030)
  • 18.9. Market Revenue, by Technology (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Volume, by Product (2017-2030)
  • 19.3. Market Revenue, by Product (2017-2030)
  • 19.4. Market Volume, by Patient Type (2017-2030)
  • 19.5. Market Revenue, by Patient Type (2017-2030)
  • 19.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 19.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 19.8. Market Volume, by Technology (2017-2030)
  • 19.9. Market Revenue, by Technology (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Volume, by Product (2017-2030)
  • 20.3. Market Revenue, by Product (2017-2030)
  • 20.4. Market Volume, by Patient Type (2017-2030)
  • 20.5. Market Revenue, by Patient Type (2017-2030)
  • 20.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 20.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 20.8. Market Volume, by Technology (2017-2030)
  • 20.9. Market Revenue, by Technology (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Volume, by Product (2017-2030)
  • 21.3. Market Revenue, by Product (2017-2030)
  • 21.4. Market Volume, by Patient Type (2017-2030)
  • 21.5. Market Revenue, by Patient Type (2017-2030)
  • 21.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 21.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 21.8. Market Volume, by Technology (2017-2030)
  • 21.9. Market Revenue, by Technology (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Volume, by Product (2017-2030)
  • 22.3. Market Revenue, by Product (2017-2030)
  • 22.4. Market Volume, by Patient Type (2017-2030)
  • 22.5. Market Revenue, by Patient Type (2017-2030)
  • 22.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 22.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 22.8. Market Volume, by Technology (2017-2030)
  • 22.9. Market Revenue, by Technology (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Volume, by Product (2017-2030)
  • 23.3. Market Revenue, by Product (2017-2030)
  • 23.4. Market Volume, by Patient Type (2017-2030)
  • 23.5. Market Revenue, by Patient Type (2017-2030)
  • 23.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 23.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 23.8. Market Volume, by Technology (2017-2030)
  • 23.9. Market Revenue, by Technology (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Volume, by Product (2017-2030)
  • 24.3. Market Revenue, by Product (2017-2030)
  • 24.4. Market Volume, by Patient Type (2017-2030)
  • 24.5. Market Revenue, by Patient Type (2017-2030)
  • 24.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 24.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 24.8. Market Volume, by Technology (2017-2030)
  • 24.9. Market Revenue, by Technology (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Volume, by Product (2017-2030)
  • 25.3. Market Revenue, by Product (2017-2030)
  • 25.4. Market Volume, by Patient Type (2017-2030)
  • 25.5. Market Revenue, by Patient Type (2017-2030)
  • 25.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 25.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 25.8. Market Volume, by Technology (2017-2030)
  • 25.9. Market Revenue, by Technology (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Volume, by Product (2017-2030)
  • 26.3. Market Revenue, by Product (2017-2030)
  • 26.4. Market Volume, by Patient Type (2017-2030)
  • 26.5. Market Revenue, by Patient Type (2017-2030)
  • 26.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 26.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 26.8. Market Volume, by Technology (2017-2030)
  • 26.9. Market Revenue, by Technology (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Volume, by Product (2017-2030)
  • 27.3. Market Revenue, by Product (2017-2030)
  • 27.4. Market Volume, by Patient Type (2017-2030)
  • 27.5. Market Revenue, by Patient Type (2017-2030)
  • 27.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 27.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 27.8. Market Volume, by Technology (2017-2030)
  • 27.9. Market Revenue, by Technology (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Volume, by Product (2017-2030)
  • 28.3. Market Revenue, by Product (2017-2030)
  • 28.4. Market Volume, by Patient Type (2017-2030)
  • 28.5. Market Revenue, by Patient Type (2017-2030)
  • 28.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 28.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 28.8. Market Volume, by Technology (2017-2030)
  • 28.9. Market Revenue, by Technology (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Audina Hearing Instruments Inc.
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Amplifon SpA
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. GN Group
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Horentek Hearing Diagnostics
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. Cochlear Ltd.
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Abbott Laboratories
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Sonova Holding AG
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. Sivantos Group
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. EunSung
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary
  • 30.10. Arphi Electronics Private Limited
    • 30.10.1. Business overview
    • 30.10.2. Product and service offerings
    • 30.10.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports